Skip to main content
Top
Published in: Angiogenesis 2/2018

Open Access 01-05-2018 | Original Paper

Oxidized phospholipids stimulate production of stem cell factor via NRF2-dependent mechanisms

Authors: Taras Afonyushkin, Olga V. Oskolkova, Valery N. Bochkov

Published in: Angiogenesis | Issue 2/2018

Login to get access

Abstract

Receptor tyrosine kinase c-Kit and its ligand stem cell factor (SCF) regulate resident vascular wall cells and recruit circulating progenitors. We tested whether SCF may be induced by oxidized palmitoyl-arachidonoyl-phosphatidylcholine (OxPAPC) known to accumulate in atherosclerotic vessels. Gene expression analysis demonstrated OxPAPC-induced upregulation of SCF mRNA and protein in different types of endothelial cells (ECs). Elevated levels of SCF mRNA were observed in aortas of ApoE−/− knockout mice. ECs produced biologically active SCF because conditioned medium from OxPAPC-treated cells stimulated activation (phosphorylation) of c-Kit in naïve ECs. Induction of SCF by OxPAPC was inhibited by knocking down transcription factor NRF2. Inhibition or stimulation of NRF2 by pharmacological or molecular tools induced corresponding changes in SCF expression. Finally, we observed decreased levels of SCF mRNA in aortas of NRF2 knockout mice. We characterize OxPLs as a novel pathology-associated stimulus inducing expression of SCF in endothelial cells. Furthermore, our data point to transcription factor NRF2 as a major mediator of OxPL-induced upregulation of SCF. This mechanism may represent one of the facets of pleiotropic action of NRF2 in vascular wall.
Appendix
Available only for authorised users
Literature
4.
go back to reference Broudy VC, Kovach NL, Bennett LG et al (1994) Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor. Blood 83:2145–2152PubMed Broudy VC, Kovach NL, Bennett LG et al (1994) Human umbilical vein endothelial cells display high-affinity c-kit receptors and produce a soluble form of the c-kit receptor. Blood 83:2145–2152PubMed
7.
go back to reference Koenig A, Yakisan E, Reuter M et al (1994) Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation. Blood 83:2836–2843PubMed Koenig A, Yakisan E, Reuter M et al (1994) Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation. Blood 83:2836–2843PubMed
8.
go back to reference Miyamoto T, Sasaguri Y, Sasaguri T et al (1997) Expression of stem cell factor in human aortic endothelial and smooth muscle cells. Atherosclerosis 129:207–213CrossRefPubMed Miyamoto T, Sasaguri Y, Sasaguri T et al (1997) Expression of stem cell factor in human aortic endothelial and smooth muscle cells. Atherosclerosis 129:207–213CrossRefPubMed
26.
go back to reference Flanagan JG, Chan DC, Leder P (1991) Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 64:1025–1035CrossRefPubMed Flanagan JG, Chan DC, Leder P (1991) Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 64:1025–1035CrossRefPubMed
30.
go back to reference Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK (2005) Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 280:16891–16900. https://doi.org/10.1074/jbc.M500166200 CrossRefPubMed Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK (2005) Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 280:16891–16900. https://​doi.​org/​10.​1074/​jbc.​M500166200 CrossRefPubMed
31.
go back to reference Buzby JS, Knoppel EM, Cairo MS (1994) Coordinate regulation of Steel factor, its receptor (Kit), and cytoadhesion molecule (ICAM-1 and ELAM-1) mRNA expression in human vascular endothelial cells of differing origins. Exp Hematol 22:122–129PubMed Buzby JS, Knoppel EM, Cairo MS (1994) Coordinate regulation of Steel factor, its receptor (Kit), and cytoadhesion molecule (ICAM-1 and ELAM-1) mRNA expression in human vascular endothelial cells of differing origins. Exp Hematol 22:122–129PubMed
37.
38.
go back to reference Watson AD, Leitinger N, Navab M et al (1997) Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272:13597–13607CrossRefPubMed Watson AD, Leitinger N, Navab M et al (1997) Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272:13597–13607CrossRefPubMed
Metadata
Title
Oxidized phospholipids stimulate production of stem cell factor via NRF2-dependent mechanisms
Authors
Taras Afonyushkin
Olga V. Oskolkova
Valery N. Bochkov
Publication date
01-05-2018
Publisher
Springer Netherlands
Published in
Angiogenesis / Issue 2/2018
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-017-9590-5

Other articles of this Issue 2/2018

Angiogenesis 2/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.